Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
26.09
-0.18 (-0.70%)
Streaming Delayed Price
Updated: 9:46 AM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,062,096
Open
26.27
Bid (Size)
26.08 (11)
Ask (Size)
26.09 (15)
Prev. Close
26.27
Today's Range
26.08 - 26.43
52wk Range
25.23 - 40.37
Shares Outstanding
5,606,688,356
Dividend Yield
6.29%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Today 8:30 EDT
The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Today 7:54 EDT
Via
Benzinga
Performance
YTD
-12.26%
-12.26%
1 Month
-4.90%
-4.90%
3 Month
-7.92%
-7.92%
6 Month
-15.12%
-15.12%
1 Year
-33.68%
-33.68%
More News
Read More
Pfizer Declares Second-Quarter 2024 Dividend
April 24, 2024
From
Pfizer Inc.
Via
Business Wire
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
April 24, 2024
Via
InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Creative Biolabs: The Way ADCs Are Made Has Changed
April 23, 2024
Via
Get News
US Stock: Pfizer
April 23, 2024
Via
Talk Markets
3 Defensive Stocks To Protect Your Portfolio In 2024
April 23, 2024
Via
Talk Markets
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
Via
InvestorPlace
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
Via
The Motley Fool
Pfizer Options Trading: A Deep Dive into Market Sentiment
April 22, 2024
Via
Benzinga
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Wednesday Trading
April 17, 2024
Via
Investor Brand Network
Exposures
COVID-19
A Closer Look at Pfizer's Options Market Dynamics
April 15, 2024
Via
Benzinga
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
April 22, 2024
Via
InvestorPlace
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024
From
Pfizer Inc.
Via
Business Wire
Capturing Consumer Spending on Health Care with XLV
April 22, 2024
Via
News Direct
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
April 20, 2024
Via
The Motley Fool
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
April 18, 2024
Via
The Motley Fool
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
April 17, 2024
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $100 Right Now
April 17, 2024
Via
The Motley Fool
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
Via
Benzinga
Pneumococcal Pneumonia Vaccination Can Save Your Life
April 16, 2024
Via
StatePoint Media
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.